Home › Companies › IDEAYA BIOSCIENCES INC. › 2024-2025

IDEAYA BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and IDEAYA BIOSCIENCES INC.’s Form 8-K, filed 2025-06-24 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 6Reported items
  • 233Asset managers
  • 990Fund votes
  • 2025-06-24Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore IDEAYA BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by IDEAYA BIOSCIENCES INC.

These tallies are IDEAYA BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-24 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

IDEAYA BIOSCIENCES INC. — official shareholder meeting results, meeting held 2025-06-24
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Jeffrey L. Stein, Ph.D. 69,077,770---- 7,955,9483,030,741 Majority: yes
Elect Director: Scott W. Morrison 42,132,938---- 34,900,7803,030,741 Majority: yes

Source: IDEAYA BIOSCIENCES INC., Form 8-K, filed with the SEC on 2025-06-24 — read the filing on EDGAR.

How asset managers voted at the IDEAYA BIOSCIENCES INC. 2024-2025 meeting

Each item below shows how the 233 asset managers that disclosed a IDEAYA BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IDEAYA BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-24.

Combines 8 wordings of this item as funds reported it.

79% fund support · no official result

FOR 79%AGAINST 21%

The 219 asset managers below cast 79% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR: 79.3%AGAINST: 20.5%ABSTAIN: 0.0%SPLIT: 0.2%NOT VOTED: 0.0%
Largest asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as di” at IDEAYA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity22,520,86734,685 00For
Federated Hermes9,257,0520 00For
BlackRock1,621,3606,352,734 00Against
Janus Henderson5,771,8880 00For
Vanguard5,201,7630 00For
State Street4,659,5884,834 00For
T. Rowe Price4,043,4100 00For
DEERFIELD MANAGEMENT COMPANY, L.P.3,915,3110 00For
Capital Group02,844,923 00Against
Capital Research Global Investors02,844,923 00Against
Point722,593,9950 00For
Logos Global Management LP02,555,115 00Against
GEODE CAPITAL MANAGEMENT, LLC2,111,5220 00For
JANUS INVESTMENT FUND2,008,3030 00For
PICTET ASSET MANAGEMENT SA1,692,7260 00For
Charles Schwab01,435,700 00Against
Sofinnova Investments, Inc.1,294,0000 00For
Fiera Capital Corp1,153,2110 00For
Aberdeen882,6100 00For
MUTUAL FUND SERIES TRUST771,8440 00For
Fisher Asset Management, LLC621,61547,804 00For
DAFNA Capital Management LLC651,8300 00For
Northern Trust640,1160 00For
Redmile Group, LLC0490,996 00Against
Citadel400,7170 00For

Showing the 25 largest of 219 asset managers. See all 219 in the interactive database.

2. To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Jeffery L. Stein. Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-24.

Combines 4 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%
FOR: 69,077,770WITHHELD: 7,955,948

IDEAYA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Jeffrey L. Stein, Ph.D.”): 69,077,770 for, 7,955,948 withheld, per its Form 8-K filed 2025-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 87,565,252 outstanding shares: 79% for, 9% withheld (88% of the company cast a for/withheld vote).

The 63 asset managers below cast 100% of the shares they voted on this item FOR (31,449,325 for, 0 against).

FOR 89%11%
FOR: 31,449,325 (89.0%)ABSTAIN: 3,886,787 (11.0%)
Largest asset managers voting on “To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their s” at IDEAYA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity9,391,0440 34,6850For
Vanguard4,962,2170 00For
Federated Hermes4,628,5260 00For
BlackRock614,0850 3,378,6090Abstain
Capital Group2,844,9230 00For
JANUS INVESTMENT FUND2,008,3030 00For
T. Rowe Price1,658,0540 00For
State Street1,489,0140 00For
MUTUAL FUND SERIES TRUST771,8440 00For
Charles Schwab717,3220 00For
Aberdeen441,3050 00For
TIAA284,3110 00For
GENERAL AMERICAN INVESTORS CO INC260,2610 00For
Equitable6,0830 234,4260Abstain
Victory Capital157,6440 00For
New York Life156,9390 00For
QUANTITATIVE MASTER SERIES LLC00 148,6470Abstain
Jackson National131,0900 5340For
Exchange Place Advisors Trust115,1500 00For
Tema ETF Trust65,1340 00For
Lincoln Financial63,9000 3590For
ALPS ETF Trust61,0020 00For
MASTER INVESTMENT PORTFOLIO56,5440 00For
Global X52,3660 00For
Brighthouse29,9410 19,9530For

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

3. To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Scott W. Morrison

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-24.

Combines 4 wordings of this item as funds reported it.

54.7% Majority: yes · of votes cast

FOR 54.7%WITHHELD 45.3%
FOR: 42,132,938WITHHELD: 34,900,780

IDEAYA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Scott W. Morrison”): 42,132,938 for, 34,900,780 withheld, per its Form 8-K filed 2025-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 87,565,252 outstanding shares: 48.1% for, 40% withheld (88% of the company cast a for/withheld vote).

The 63 asset managers below cast 100% of the shares they voted on this item FOR (22,484,073 for, 0 against).

FOR 64%ABSTAIN 36%
FOR: 22,484,073 (63.6%)ABSTAIN: 12,852,039 (36.4%)
Largest asset managers voting on “To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their s” at IDEAYA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity9,283,3660 142,3630For
Vanguard4,962,2170 00For
Federated Hermes00 4,628,5260Abstain
BlackRock00 3,992,6940Abstain
Capital Group2,844,9230 00For
JANUS INVESTMENT FUND2,008,3030 00For
T. Rowe Price1,658,0540 00For
State Street4,2620 1,484,7520Abstain
MUTUAL FUND SERIES TRUST771,8440 00For
Charles Schwab00 717,3220Abstain
Aberdeen00 441,3050Abstain
TIAA284,3110 00For
GENERAL AMERICAN INVESTORS CO INC260,2610 00For
Equitable6,0830 234,4260Abstain
Victory Capital00 157,6440Abstain
New York Life138,4240 18,5150For
QUANTITATIVE MASTER SERIES LLC00 148,6470Abstain
Jackson National131,0900 5340For
Exchange Place Advisors Trust00 115,1500Abstain
Tema ETF Trust65,1340 00For
Lincoln Financial00 64,2590Abstain
ALPS ETF Trust00 61,0020Abstain
MASTER INVESTMENT PORTFOLIO00 56,5440Abstain
Global X00 52,3660Abstain
Brighthouse00 49,8940Abstain

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

4. To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025;

AUDIT-RELATED

Meeting held 2025-06-24.

Combines 4 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (35,314,423 for, 1,693 against).

FOR: 35,314,423 (99.9%)AGAINST: 1,693 (0.0%)ABSTAIN: 19,953 (0.1%)
Largest asset managers voting on “To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers” at IDEAYA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity9,425,7290 00For
Vanguard4,962,2170 00For
Federated Hermes4,628,5260 00For
BlackRock3,992,6940 00For
Capital Group2,844,9230 00For
JANUS INVESTMENT FUND2,008,3030 00For
T. Rowe Price1,658,0540 00For
State Street1,488,92787 00For
MUTUAL FUND SERIES TRUST771,8440 00For
Charles Schwab717,3220 00For
Aberdeen441,3050 00For
TIAA284,3110 00For
GENERAL AMERICAN INVESTORS CO INC260,2610 00For
Equitable240,5090 00For
Victory Capital157,6440 00For
New York Life156,9390 00For
QUANTITATIVE MASTER SERIES LLC148,6470 00For
Jackson National131,6240 00For
Exchange Place Advisors Trust115,1500 00For
Tema ETF Trust65,1340 00For
Lincoln Financial64,2590 00For
ALPS ETF Trust61,0020 00For
MASTER INVESTMENT PORTFOLIO56,5440 00For
Global X52,3660 00For
Brighthouse29,9410 19,9530For

Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.

5. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-24.

88% fund support · no official result

FOR 88%12%

The 9 asset managers below cast 88% of the shares they voted on this item FOR (1,050,489 for, 138,372 against).

FOR: 1,050,489 (88.4%)AGAINST: 138,372 (11.6%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at IDEAYA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
ADAGE CAPITAL PARTNERS GP, L.L.C.948,6940 00For
ALGERT GLOBAL LLC0136,940 00Against
JPMorgan74,4080 00For
Metzler Asset Management GmbH27,2760 00For
Desjardins Global Asset Management Inc.01,132 00Against
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma0300 00Against
UNIFIED SERIES TRUST430 00For
Coyle Financial Counsel LLC340 00For
SIERRA SUMMIT ADVISORS LLC340 00For

6. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2024-05-31 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

0% fund support · no official result

AGAINST 100%

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 84 against).

AGAINST: 84 (100.0%)
Largest asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as di” at IDEAYA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
COLDSTREAM CAPITAL MANAGEMENT INC084 00Against
Echo45 Advisors LLC00 00--

Largest IDEAYA BIOSCIENCES INC. shareholders voting in 2024-2025

Ranked by the number of IDEAYA BIOSCIENCES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 87,565,252 shares outstanding at the time of that meeting.

Top IDEAYA BIOSCIENCES INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Fidelity 25.76%
2Federated Hermes 10.57%
3BlackRock 9.11%
4Janus Henderson 6.59%
5Vanguard 5.94%
6State Street 5.33%
7T. Rowe Price 4.62%
8DEERFIELD MANAGEMENT COMPANY, L.P. 4.47%
9Capital Group 3.25%
10Capital Research Global Investors 3.25%

Reported IDEAYA BIOSCIENCES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

IDEAYA BIOSCIENCES INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
FMR (Fidelity) 15.00% 13F
FMR LLC 14.43% DEF14A
BlackRock 10.46% 13F
JANUS HENDERSON GROUP PLC 8.30% 13G
Vanguard Group 5.82% 13F
T. Rowe Price 3.97% 13F
State Street 3.94% 13F
Federated Hermes, Inc. 3.88% 13G
Geode Capital 2.38% 13F
Point72 Asset Management, L.P. 2.11% 13G

Percentages above are of 87,565,252 shares outstanding, as reported by IDEAYA BIOSCIENCES INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IDEAYA BIOSCIENCES INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At IDEAYA BIOSCIENCES INC.'s shareholder meeting held 2025-06-24, in the 2024-2025 proxy season, 233 asset managers reported how they voted in their SEC Form N-PX filings, covering 990 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. IDEAYA BIOSCIENCES INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on a non-binding, advisory basis, the compensation of the Company's named executive… — the reporting funds cast 79% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

IDEAYA BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.